CKAP2L, a crucial target of miR-326, promotes prostate cancer progression. Li Q, Yan M, Wang C, Wang K, et al. BMC Cancer 2022;22:666.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li Q, Yan M, Wang C, Wang K, et al. CKAP2L, a crucial target of miR-326, promotes prostate cancer progression. BMC Cancer 2022;22:666.
PMID: 35715760